Studies examining hemoglobin (Hb)-induced changes in cancer survival and progression are uncommon in the literature; nonetheless, a novel study by Yin et al. [3] provided new evidence that red blood cells (RBCs) and Hb activate the reactive oxygen species-NF-κB pathway in both tumor cells and macrophages. The gene discussed is NFKB1; the disease is cancer.